A Clinical Study on the Effect of Discontinuing Alendronate in Postmenopausal Women With Osteoporosis After a Treatment Period Without Fractures

NCT06864130 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

1400

Enrollment

OTHER

Sponsor class

Conditions

Osteoporosis in Post-menopausal Women

Interventions

DRUG: Alendronate 70mg weekly

Sponsor

Odense University Hospital